Throughout his Twitter Account, this what Senator Olekina tweeted. "CS Kagwe stop giving Kenyans hope that you will receive 4M doses of AstraZeneca in June from India! A Country that recorded 170k New Covid cases in a day! Allow Sputnik V Vaccines to Continue. Infact since you only have 1.1M AstraZeneca doses stop 550k to guarantee Second dose." Tweeted Sen Ledama Olekina
Kenyans have been doubting Mutahi Kagwe's Results on Covid-19. Kenyans once stated that Kagwe was just giving out fake Covid-19 Results, so that the Government can get Foreign loans and Donations.
Minister Mutahi Kagwe and his team have been giving details to the Citizens of Kenya, that they were planning to Import Covid-19 Vaccine from India. This is after confirming that the AstraZeneca Vaccine had some health effects.
According to my own Considered Opinion, CS Mutahi Kagwe and his team are trying to play with Kenyans for their own Personal Interests.
Content created and supplied by: IddAbia (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More